Updated Sep 13
Jun 17, 2026
Anthropic Forced to Pull Fable 5 AI Model After White House Export Ban
The Trump administration forced Anthropic to disable its newest Fable 5 and Mythos 5 AI models after Amazon flagged a jailbreak vulnerability. The unprecedented export control order is sending shockwaves through the AI industry, accelerating open-source adoption and raising existential questions for builders who rely on closed models.
anthropicfable-5mythos-5
Jun 17, 2026
SpaceX Acquires Cursor for $60 Billion in First Post-IPO Power Move
SpaceX is buying AI coding startup Cursor for $60 billion in an all-stock deal, its first major acquisition since going public. The deal gives Elon Musk's company access to Cursor's 1 million-plus developers and a foothold in the fast-growing AI coding tools market.
spacexcursoranysphere
Jun 16, 2026
Trump Administration Forces Anthropic to Pull Fable 5 and Mythos 5 Offline
The U.S. Commerce Department ordered Anthropic to block foreign access to its newest Fable 5 and Mythos 5 AI models, forcing a total shutdown. The directive, triggered by an Amazon security paper and a three-word jailbreak prompt, has sparked a global sovereign AI backlash from the UK, France, and Canada.
anthropicfable-5mythos-5
Related News
Oct 29, 2026
Navatar brings Claude suggestions and user-initiated work into its deal CRM
The October 29 release adds a Navatar starting point for Claude work. Returning a result, selectively updating fields and making activity visible to authorized colleagues are separate parts of the workflow.
NavatarClaudeSalesforce
Oct 28, 2026
Claude Calendar and Gmail connector incidents resolved: impact windows and notice times
Anthropic marked two connector incidents resolved on October 28. Calendar list/search and Gmail search/read had different reported impact windows, which ended before their resolution notices were posted.
ClaudeGoogle CalendarGmail
Oct 28, 2026
Anthropic outlines six drug-development partnerships and in-house Mithril work
Anthropic’s October 27 update separates external research collaborations from Mithril Medicine work now inside the company. It describes early research involvement, not an acquisition closing date or a clinical result.
AnthropicClaudeMithril Medicine